Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Measuring Dorsoventral Pattern and Morphogen Signaling Profiles in the Growing Neural Tube.

Zagorski M, Kicheva A.

Methods Mol Biol. 2018;1863:47-63. doi: 10.1007/978-1-4939-8772-6_4.

PMID:
30324592
2.

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis.

Pappolla MA, Matsubara E, Vidal R, Pacheco-Quinto J, Poeggeler B, Zagorski M, Sambamurti K.

Curr Alzheimer Res. 2018;15(7):637-642. doi: 10.2174/1567205015666180411092551.

PMID:
29637859
3.

Interaction networks, ecological stability, and collective antibiotic tolerance in polymicrobial infections.

de Vos MGJ, Zagorski M, McNally A, Bollenbach T.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10666-10671. doi: 10.1073/pnas.1713372114. Epub 2017 Sep 18.

4.

Decoding of position in the developing neural tube from antiparallel morphogen gradients.

Zagorski M, Tabata Y, Brandenberg N, Lutolf MP, Tkačik G, Bollenbach T, Briscoe J, Kicheva A.

Science. 2017 Jun 30;356(6345):1379-1383. doi: 10.1126/science.aam5887.

5.

Ischaemic preconditioning - Current knowledge and potential future applications after 30 years of experience.

Stokfisz K, Ledakowicz-Polak A, Zagorski M, Zielinska M.

Adv Med Sci. 2017 Sep;62(2):307-316. doi: 10.1016/j.advms.2016.11.006. Epub 2017 May 13. Review.

PMID:
28511069
6.

Beyond the Hypercube: Evolutionary Accessibility of Fitness Landscapes with Realistic Mutational Networks.

Zagorski M, Burda Z, Waclaw B.

PLoS Comput Biol. 2016 Dec 9;12(12):e1005218. doi: 10.1371/journal.pcbi.1005218. eCollection 2016 Dec.

7.

Drivers of structural features in gene regulatory networks: From biophysical constraints to biological function.

Martin OC, Krzywicki A, Zagorski M.

Phys Life Rev. 2016 Jul;17:124-58. doi: 10.1016/j.plrev.2016.06.002. Epub 2016 Jun 23. Review.

PMID:
27365153
8.

Network architectures and operating principles: Reply to comments on "Drivers of structural features in gene regulatory networks: From biophysical constraints to biological function".

Martin OC, Zagorski M.

Phys Life Rev. 2016 Jul;17:168-71. doi: 10.1016/j.plrev.2016.06.006. Epub 2016 Jun 22. No abstract available.

PMID:
27365152
9.

Disparities in physical activity resource availability in six US regions.

Jones SA, Moore LV, Moore K, Zagorski M, Brines SJ, Diez Roux AV, Evenson KR.

Prev Med. 2015 Sep;78:17-22. doi: 10.1016/j.ypmed.2015.05.028. Epub 2015 Jun 9.

10.

Changes in the built environment and changes in the amount of walking over time: longitudinal results from the multi-ethnic study of atherosclerosis.

Hirsch JA, Moore KA, Clarke PJ, Rodriguez DA, Evenson KR, Brines SJ, Zagorski MA, Diez Roux AV.

Am J Epidemiol. 2014 Oct 15;180(8):799-809. doi: 10.1093/aje/kwu218. Epub 2014 Sep 18.

11.

Built environment change and change in BMI and waist circumference: Multi-ethnic Study of Atherosclerosis.

Hirsch JA, Moore KA, Barrientos-Gutierrez T, Brines SJ, Zagorski MA, Rodriguez DA, Diez Roux AV.

Obesity (Silver Spring). 2014 Nov;22(11):2450-7. doi: 10.1002/oby.20873. Epub 2014 Aug 18.

12.

Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation.

Hou L, Lee HG, Han F, Tedesco JM, Perry G, Smith MA, Zagorski MG.

J Alzheimers Dis. 2013;37(1):9-18. doi: 10.3233/JAD-122389.

PMID:
23719512
13.

Record-setting algal bloom in Lake Erie caused by agricultural and meteorological trends consistent with expected future conditions.

Michalak AM, Anderson EJ, Beletsky D, Boland S, Bosch NS, Bridgeman TB, Chaffin JD, Cho K, Confesor R, Daloglu I, Depinto JV, Evans MA, Fahnenstiel GL, He L, Ho JC, Jenkins L, Johengen TH, Kuo KC, Laporte E, Liu X, McWilliams MR, Moore MR, Posselt DJ, Richards RP, Scavia D, Steiner AL, Verhamme E, Wright DM, Zagorski MA.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6448-52. doi: 10.1073/pnas.1216006110. Epub 2013 Apr 1.

14.

Edge usage, motifs, and regulatory logic for cell cycling genetic networks.

Zagorski M, Krzywicki A, Martin OC.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jan;87(1):012727. Epub 2013 Jan 30.

PMID:
23410379
15.

Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.

Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki J, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M.

J Biol Chem. 2012 Apr 27;287(18):14631-43. doi: 10.1074/jbc.M111.325456. Epub 2012 Mar 5.

16.

Motifs emerge from function in model gene regulatory networks.

Burda Z, Krzywicki A, Martin OC, Zagorski M.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17263-8. doi: 10.1073/pnas.1109435108. Epub 2011 Sep 29.

17.

[Application of activated eptacog alfa in cardiac surgery].

Zagórski M, Goch A.

Pol Merkur Lekarski. 2011 Jul;31(181):15-9. Polish.

PMID:
21870703
18.

Distribution of essential interactions in model gene regulatory networks under mutation-selection balance.

Burda Z, Krzywicki A, Martin OC, Zagorski M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Jul;82(1 Pt 1):011908. Epub 2010 Jul 14.

PMID:
20866649
19.

The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events.

Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT.

Mol Neurodegener. 2009 Mar 16;4:14. doi: 10.1186/1750-1326-4-14.

20.

Educational ultrasound nondestructive testing laboratory.

Genis V, Zagorski M.

J Acoust Soc Am. 2008 Sep;124(3):1411-8. doi: 10.1121/1.2966175.

PMID:
19045633
21.

Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies.

Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, Perry G, Zagorski MG.

J Biol Chem. 2008 Aug 15;283(33):22550-6. doi: 10.1074/jbc.M802088200. Epub 2008 May 27.

22.

Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.

Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA.

J Neurochem. 2008 Aug;106(3):1350-6. doi: 10.1111/j.1471-4159.2008.05477.x. Epub 2008 May 12.

23.

Amyloid aggregation inhibitors.

Zagorski MG.

IDrugs. 1998 May;1(1):17-8.

PMID:
18465494
24.

[Histopathologic diagnosis of infectious loosening of joint prostheses].

Bos I, Zagorski M, Boos C, Krüger S.

Pathologe. 2008 Jul;29(4):280-6. German.

PMID:
17639398
25.

NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

Hou L, Zagorski MG.

J Am Chem Soc. 2006 Jul 26;128(29):9260-1.

PMID:
16848423
26.

Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.

Apetri MM, Maiti NC, Zagorski MG, Carey PR, Anderson VE.

J Mol Biol. 2006 Jan 6;355(1):63-71. Epub 2005 Nov 10.

PMID:
16303137
27.

ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures.

Srinivasan R, Marchant RE, Zagorski MG.

Amyloid. 2004 Mar;11(1):10-3.

PMID:
15185493
28.

Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein.

Maiti NC, Apetri MM, Zagorski MG, Carey PR, Anderson VE.

J Am Chem Soc. 2004 Mar 3;126(8):2399-408.

PMID:
14982446
29.

Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.

Hou L, Shao H, Zhang Y, Li H, Menon NK, Neuhaus EB, Brewer JM, Byeon IJ, Ray DG, Vitek MP, Iwashita T, Makula RA, Przybyla AB, Zagorski MG.

J Am Chem Soc. 2004 Feb 25;126(7):1992-2005.

PMID:
14971932
30.

Sorting out the driving forces for parallel and antiparallel alignment in the abeta peptide fibril structure.

Hou L, Zagorski MG.

Biophys J. 2004 Jan;86(1 Pt 1):1-2. No abstract available.

31.

pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia.

Srinivasan R, Jones EM, Liu K, Ghiso J, Marchant RE, Zagorski MG.

J Mol Biol. 2003 Nov 7;333(5):1003-23.

PMID:
14583196
32.

Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease.

Hou L, Kang I, Marchant RE, Zagorski MG.

J Biol Chem. 2002 Oct 25;277(43):40173-6. Epub 2002 Aug 26.

33.

Intramolecular quenching of tryptophan fluorescence by the peptide bond in cyclic hexapeptides.

Adams PD, Chen Y, Ma K, Zagorski MG, Sönnichsen FD, McLaughlin ML, Barkley MD.

J Am Chem Soc. 2002 Aug 7;124(31):9278-86.

PMID:
12149035
34.

Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide.

Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, Shao H, Bryant-Thomas T, Vidal R, Frangione B, Ghiso J, Pappolla MA.

Biochemistry. 2001 Dec 11;40(49):14995-5001.

PMID:
11732920
35.

Nicotine and amyloid formation.

Zeng H, Zhang Y, Peng L, Shao H, Menon NK, Yang J, Salomon AR, Freidland RP, Zagorski MG.

Biol Psychiatry. 2001 Feb 1;49(3):248-57.

PMID:
11230876
36.

Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases.

Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sönnichsen FD.

J Biol Chem. 2000 Oct 27;275(43):33650-4.

37.

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

Zagorski MG, Yang J, Shao H, Ma K, Zeng H, Hong A.

Methods Enzymol. 1999;309:189-204. No abstract available.

PMID:
10507025
38.

Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.

Shao H, Jao S, Ma K, Zagorski MG.

J Mol Biol. 1999 Jan 15;285(2):755-73.

PMID:
9878442
39.

Inhibition of Alzheimer beta-fibrillogenesis by melatonin.

Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J.

J Biol Chem. 1998 Mar 27;273(13):7185-8.

40.

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.

Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G.

Chem Res Toxicol. 1997 May;10(5):518-26. Review. No abstract available.

PMID:
9168248
41.

Nicotine inhibits amyloid formation by the beta-peptide.

Salomon AR, Marcinowski KJ, Friedland RP, Zagorski MG.

Biochemistry. 1996 Oct 22;35(42):13568-78.

PMID:
8885836
42.

Solution structure of residues 1-28 of the amyloid beta-peptide.

Talafous J, Marcinowski KJ, Klopman G, Zagorski MG.

Biochemistry. 1994 Jun 28;33(25):7788-96.

PMID:
7516706
44.
45.

Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions.

Orlando R, Kenny PT, Zagorski MG.

Biochem Biophys Res Commun. 1992 Apr 30;184(2):686-91.

PMID:
1575742
46.

Solution structure of pardaxin P-2.

Zagorski MG, Norman DG, Barrow CJ, Iwashita T, Tachibana K, Patel DJ.

Biochemistry. 1991 Aug 13;30(32):8009-17.

PMID:
1868074
47.

Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

Barrow CJ, Zagorski MG.

Science. 1991 Jul 12;253(5016):179-82.

PMID:
1853202
48.
49.

Supplemental Content

Loading ...
Support Center